biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Deal Metrics

<< Previous

Bullboard Posts

Next >>

Comment by Georgeparroson Dec 13, 2022 11:52am

131 Views

Post# 35168642

RE:Deal Metrics

Ordinary Shares	Undiluted percentage of Enlarged Issued Share Capital following Completion	Pre-Funded Warrants (over Ordinary Shares)	Existing Warrants, A Warrants, B Warrants, Placement Agent Warrants, Ladenburg Fee Warrants (over Ordinary Shares)	Maximum number of Cresence Shares that may be issued pursuant to the Cresence Amendment Agreement	Existing Options / New Options	Fully Diluted
In issue at the date of the Announcement	98,493,413	39.8%	-	17,226,053	-	3,007,197 (Existing Options)	118,726,663	13.1%
Ordinary Shares issued pursuant to the Registered Direct Offering	9,849,325	4%	-	-	-	-	9,849,325	1.1%
In issue following Registered Direct Offering	108,342,738	43.8%	-	17,226,053	-	3,007,197 (Existing Options)	128,575,988	14.1%
Bioasis Securityholders holdings following Completion	75,884,553	30.7%	-	21,285,497	-	8,481,459 (New Options)	105,651,509	11.6%
Cresence Founders	-	-	-	-	5,733,337	-	5,733,337	0.6%
Lind holdings following Completion	20,630,531	8.3%	-	41,261,062	-	-	61,891,593	6.8%
Placee holdings following Completion	14,602,050	5.9%	225,548,625	500,000,000	-	-	514,602,050	56.6%
Ladenburg holdings following Completion	27,863,856	11.3%	-	65,333,739	-	-	93,197,595	10.2%
TOTAL FOLLOWING COMPLETION	247,323,728	100%	225,548,625	645,106,352	5,733,337	11,488,656	909,652,073	100.0%